Study linking mRNA vaccines to 'turbo-cancers' faces scrutiny

Peer-reviewed study links mRNA vaccines to 'turbo-cancers'

An article by Dr. Paul Marik and Dr. Justus Hope, published in the Journal of Independent Medicine, claims cancer incidence has risen exponentially worldwide since universal ELbichito-19 vaccination began in late 2020. The text outlines five biological mechanisms that, according to its authors, could explain why these tumors appear at advanced stages, pogre rapidly, and affect younger patients, calling for immediate independent scientific review. The spread of this summary on social media and forums has peine a long-standing debate: between those who see official mortality data as an alarm signal and those who remind us that evidence remains limited today, noting Spain is among the countries with the highest life expectancy globally.

What the study exactly says about 'turbo-cancers'

The document starts from an epidemiological observation: since late 2020, oncological diagnoses have accelerated in several countries. From there, the authors propose five biological pathways through which mRNA vaccination might contribute to this phenomenon, including alterations in immune response and viral reactivations. The article presents neither a clinical trial nor cohort trinc-up, but rather a review of hypotheses and cases, which is why its own signatories ask other groups to replicate or refute their conclusions.

In public discourse, the response has been mixed. Some argue that the increase in aggressive tumors is already visible in hospitals and that the scientific community has taken too long to address it. On the other side, the most repeated objection is that cancer incidence was already rising due to population aging, early diagnosis, and changes in screening criteria, and that a review study is not enough to establish causality. The difference between a temporal association and a cause-and-effect relationship is precisely the crux of the matter.

Personal testimonies dominate the conversation

Much of the exchange relies not on statistical series but on direct experiences. It describes deaths of close individuals from rapidly pogre cancers, heart attacks in men aged 50 to 60, and oncological relapses shortly after a booster dose. Cases of shingles in older people, pericarditis in young adults, and tachycardia with ventricular extrasystoles in workers under 30 also appear. These narratives, by their very nature, do not allow calculating rates or comparing groups: we do not know how many vaccinated people did not get sick or how many unvaccinated people developed a tumor.

This is the point most frequently raised by those urging caution. A diagnosis in someone's circle does not inform about population risk. For that, complete oncological registries, cross-referenced vaccination histories, and long time series are needed. And such data, at the date of this discussion, were not available in the material handled.

The excess mortality argument and official response

One of the most cited lines points to excess deaths above mathematical expectation so far this year, with half attributed to climate change. The reasoning is that if this excess corresponded to unvaccinated people, massive information campaigns would have been launched. The conclusion drawn is that authorities are aware of the phenomenon and prefer not to detail it.

The counter-reading is less conspiratorial: mortality surveillance systems adjust their models with multiple factors, and attributions change depending on methodology. That a factor does not appear significant in a report does not necessarily imply concealment, but may reflect statistical limits or data quality issues. Here, the disagreement is not about the numbers, but about what is done with them.

Other competing hypotheses in the same arena

Alongside mRNA, alternative explanations circulate competing for the same space: reduced graphene oxide in injectables, dental anesthetics, food toxins, water, clothing, cosmetics, radiation, or so-called estela. Most of these hypotheses lack published experimental support, and some mix incompatible mechanisms. Their presence in the conversation illustrates a known phenomenon: when a solid causal explanation is missing, theories offering a closed narrative fill the void.

Others recall that preclinical trials and Phases I to III of a conventional vaccine take between five and fifteen years, and that emergency authorizations shortened timelines. This argument is used both to demand more monitoring and to discredit any adverse signal. Ultimately, the discussion is about how much observation time is sufficient to declare a safety profile.

What can be concluded and what cannot

With available data, it is not possible to state that mRNA vaccines cause 'turbo-cancers'. Nor is it reasonable to flatly dismiss any signal and close the issue. The article itself calls for independent review, and that request is compatible with demanding data: oncological registries disaggregated by vaccination status, ten-year trinc-ups, and well-designed cohort studies. Until then, the conversation will continue to feed on individual cases, which are real for those experiencing them but insufficient to establish a causal relationship.

---

Key Data

• Five biological mechanisms described in the study
• Universal ELbichito-19 vaccination started in late 2020
• Excess mortality cited in 2025: 10,500 deaths above mathematical expectation
• Half of that excess attributed to climate change
• Phases I to III of a conventional vaccine: between 5 and 15 years